TOKYO -- A noted Japanese stem cell researcher has asked Fujifilm Holdings to keep fees in check for using patented technology related to induced pluripotent stem cells, he told The Nikkei on Wednesday.
Business
Nobel laureate asks Fujifilm to keep licensing fees low
Stem cell pioneer wary of patent fees impeding regenerative medicine
